Experiences of an inpatient penicillin allergy de-labelling pathway: capturing the patient voice.

ABSTRACT:

Background

Non-allergist-delivered penicillin allergy de-labelling (PADL) is supported by UK and other national guidelines but is not yet routine practice in UK hospitals. Those who have undergone PADL report high rates of acceptance, but it is unknown why some continue to avoid penicillin, and why some decline testing.

Objectives

To explore the experiences of patients recently approached for penicillin allergy (penA) assessment and de-label by non-allergists in a UK hospital to determine the barriers and enablers to patient acceptance of PADL.

Methods

Qualitative study using semi-structured interviews with patients who were penA assessed and de-labelled during an inpatient stay between November 2022 and January 2023. Thematic analysis was used to analyse the data.

SUBMITTER: Powell N 

PROVIDER: S-EPMC10854212 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature